Inhibitory effects of beer on heterocyclic amine-induced mutagenesis and PhIP-induced aberrant crypt foci in rat colon

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 559, Issue 1-2, 2004, Pages 177-187

  Nozawa, Hajime ^a   Tazumi, Kyoko ^a   Sato, Kaoru ^a   Yoshida, Aruto ^a   Takata, Jun ^b   Arimoto Kobayashi, Sakae ^b   Kondo, Keiji ^a  

^a KIRIN BREWERY CO LTD   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

Author keywords

2 amino 1 methyl 6 phenylimidazo 4,5 b pyridine; 2 amino 3,8 dimethylimidazo 4,5 f quinoxaline; 2 amino 3 methylimidazo 4,5 f quinoline; 3 amino 1 methyl 5H pyrido 4,3 b indole; Glu P 1; HCAs; Heterocyclic amines; IQ; MeIQx; PhIP; Trp P 2

Indexed keywords

2 AMINO 1 METHYL 6 PHENYLIMIDAZO[4,5 B]PYRIDINE; 2 AMINO 3 METHYLIMIDAZO[4,5 F]QUINOLINE; 2 AMINO 3,8 DIMETHYLIMIDAZO[4,5 F]QUINOXALINE; 2 AMINO 6 METHYLDIPYRIDO[1,2 A:3',2' D]IMIDAZOLE; 3 AMINO 1 METHYL 5H PYRIDO[4,3 B]INDOLE; ANTIMUTAGENIC AGENT; ANTINEOPLASTIC AGENT; CYTOCHROME P450 1A2; HETEROCYCLIC AMINE; PHOSPHORUS 32; S 9;

AMES TEST; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEER; CANCER RISK; CHINESE HAMSTER; COMET ASSAY; CONTROLLED STUDY; CULTURE MEDIUM; DIET SUPPLEMENTATION; DNA ADDUCT; DNA DAMAGE; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVITY; FEEDING; FREEZE DRYING; GEL ELECTROPHORESIS; GENOTOXICITY; INGESTION; ISOTOPE LABELING; LIVER CELL; LUNG ALVEOLUS CELL; MALE; MICRONUCLEUS TEST; MOUSE; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; RAT; SALMONELLA TYPHIMURIUM;

AMINES; ANIMALS; ANTIMUTAGENIC AGENTS; BEER; CELLS, CULTURED; COLON; COMET ASSAY; CRICETINAE; CRICETULUS; CYTOCHROME P-450 CYP1A2; CYTOCHROME P-450 ENZYME SYSTEM; DNA ADDUCTS; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; HETEROCYCLIC COMPOUNDS; LIVER; MICRONUCLEUS TESTS; MUTAGENESIS; OXIDOREDUCTASES; RATS; SALMONELLA TYPHIMURIUM; SPECTROMETRY, FLUORESCENCE;

CRICETINAE; CRICETULUS GRISEUS; SALMONELLA TYPHIMURIUM;

EID: 1842579604     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2004.01.008     Document Type: Article

References (43)

1. Felton J.S., Malfatti M.A., Knize M.G., Salmon C.P., Hopmans E.C., Wu R.W. Health risks of heterocyclic amines. Mutat. Res. 376:1997;37-41.
2. Sugimura T. Overview of carcinogenic heterocyclic amines. Mutat. Res. 376:1997;211-219.
3. Ito N., Hasegawa R., Sano M., Tamano S., Esumi H., Takayama S., Sugimura T. A new colon and mammary carcinogen in cooked food, 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine (PhIP). Carcinogenesis. 12:1991;1503-1506.
4. Shirai T., Sano M., Tamano S., Takahashi S., Hirose M., Futakuchi M., Hasegawa R., Imaida K., Matsumoto K., Wakabayashi K., Sugimura T., Ito N. The prostate: a target for carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5- b]pyridine (PhIP) derived from cooked foods. Cancer Res. 57:1997;195-198.
5. Sugimura T., Nagao M., Wakabayashi K. Carcinogenicity of food mutagens. Environ. Health. Perspect. 104(Suppl. 3):1996;429-433.
6. Nagao M., Wakabayashi K., Ushijima T., Toyota M., Totsuka Y., Sugimura T. Human exposure to carcinogenic heterocyclic amines and their mutational fingerprints in experimental animals. Environ. Health Perspect. 104(Suppl. 3):1996;497-501.
7. Felton J.S., Knize M.G., Shen N.H., Lewis P.R., Andresen B.D., Happe J., Hatch F.T. The isolation and identification of a new mutagen from fried ground beef: 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Carcinogenesis. 7:1986;1081-1086.
8. Layton D.W., Bogen K.T., Knize M.G., Hatch F.T., Johnson V.M., Felton J.S. Cancer risk of heterocyclic amines in cooked foods: an analysis and implications for research. Carcinogenesis. 16:1995;39-52.
9. Turesky R.J., Rossi S.C., Welti D.H., Lay J.O. Jr., Kadlubar F.F. Characterization of DNA adducts formed in vitro by reaction of N-hydroxy-2-amino-3-methylimidazo[4,5-f]quinoline and N-hydroxy-2-amino-3,8- dimethylimidazo[4,5-f]quinoxaline at the C-8 and N2 atoms of guanine. Chem. Res. Toxicol. 5:1992;479-490.
10. Turesky R.J., Constable A., Richoz J., Varga N., Markovic J., Martin M.V., Guengerich F.P. Activation of heterocyclic aromatic amines by rat and human liver microsomes and by purified rat and human cytochrome P450 1A2. Chem. Res. Toxicol. 11:1998;925-936.
11. Minchin R.F., Reeves P.T., Teitel C.H., McManus M.E., Mojarrabi B., Ilett K.F., Kadlubar F.F. N-and O-acetylation of aromatic and heterocyclic amine carcinogens by human monomorphic and polymorphic acetyltransferases expressed in COS-1 cells. Biochem. Biophys. Res. Commun. 185:1992;839-844.
12. Chou H.C., Lang N.P., Kadlubar F.F. Metabolic activation of N-hydroxy arylamines and N-hydroxy heterocyclic amines by human sulfotransferase(s). Cancer Res. 55:1995;525-529.
13. Apostolides Z., Balentine D.A., Harbowy M.E., Hara Y., Weisburger J.H. Inhibition of PhIP mutagenicity by catechins, and by theaflavins and gallate esters. Mutat. Res. 389:1997;167-172.
14. Edenharder R., Rauscher R., Platt K.L. The inhibition by flavonoids of 2-amino-3-methylimidazo[4,5-f]quinoline metabolic activation to a mutagen: a structure-activity relationship study. Mutat. Res. 379:1997;21-32.
15. Dashwood R., Yamane S., Larsen R. Study of the forces of stabilizing complexes between chlorophylls and heterocyclic amine mutagens. Environ. Mol. Mutagen. 27:1996;211-218.
16. Kensler T.W. Chemoprevention by inducers of carcinogen detoxication enzymes. Environ. Health Perspect. 105(Suppl. 4):1997;965-970.
17. Sanyal R., Darroudi F., Parzefall W., Nagao M., Knasmuller S. Inhibition of the genotoxic effects of heterocyclic amines in human derived hepatoma cells by dietary bioantimutagens. Mutagenesis. 12:1997;297-303.
18. Singh N.P., McCoy M.T., Tice R.R., Schneider E.L. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. 175:1988;184-191.
19. Sasaki Y.F., Tsuda S., Izumiyama F., Nishidate E. Detection of chemically induced DNA lesions in multiple mouse organs (liver, lung, spleen, kidney, and bone marrow) using the alkaline single cell gel electrophoresis (Comet) assay. Mutat. Res. 388:1997;33-44.
20. Kassie F., Uhl M., Rabot S., Grasl-Kraupp B., Verkerk R., Kundi M., Chabicovsky M., Schulte-Hermann R., Knasmuller S. Chemoprevention of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ)-induced colonic and hepatic preneoplastic lesions in the F344 rat by cruciferous vegetables administered simultaneously with the carcinogen. Carcinogenesis. 24:2003;255-261.
21. Tice R.R., Agurell E., Anderson D., Burlinson B., Hartmann A., Kobayashi H., Miyamae Y., Rojas E., Ryu J.C., Sasaki Y.F. Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ. Mol. Mutagen. 35:2000;206-221.
22. Lin D.X., Thompson P.A., Teitel C., Chen J.S., Kadlubar F.F. Direct reduction of N-acetoxy-PhIP by tea polyphenols: a possible mechanism for chemoprevention against PhIP-DNA adduct formation. Mutat. Res. 523-524:2003;193-200.
23. Bird R.P. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett. 37:1987;147-151.
24. Wargovich M.J., Jimenez A., McKee K., Steele V.E., Velasco M., Woods J., Price R., Gray K., Kelloff G.J. Efficacy of potential chemopreventive agents on rat colon aberrant crypt formation and progression. Carcinogenesis. 21:2000;1149-1155.
25. Takahashi M., Totsuka Y., Masuda M., Fukuda K., Oguri A., Yazawa K., Sugimura T., Wakabayashi K. Reduction in formation of 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine (PhIP)-induced aberrant crypt foci in the rat colon by docosahexaenoic acid (DHA). Carcinogenesis. 18:1997;1937-1941.
26. Chewonarin T., Kinouchi T., Kataoka K., Arimochi H., Kuwahara T., Vinitketkumnuen U., Ohnishi Y. Effects of roselle (Hibiscus sabdariffa Linn.), a Thai medicinal plant, on the mutagenicity of various known mutagens in Salmonella typhimurium and on formation of aberrant crypt foci induced by the colon carcinogens azoxymethane and 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine in F344 rats. Food Chem. Toxicol. 37:1999;591-601.
27. Lapcik O., Hill M., Hampl R., Wahala K., Adlercreutz H. Identification of isoflavonoids in beer. Steroids. 63:1998;14-20.
28. Madigan D., McMurrough I., Smyth M.R. Determination of proanthocyanidins and catechins in beer and barley by high-performance liquid chromatography with dual-electrode electrochemical detection. Analyst. 119:1994;863-868.
29. Arimoto-Kobayashi S., Sugiyama C., Harada N., Takeuchi M., Takemura M., Hayatsu H. Inhibitory effects of beer and other alcoholic beverages on mutagenesis and DNA adduct formation induced by several carcinogens. J. Agric. Food Chem. 47:1999;221-230.
30. Kimura S., Hayatsu H., Arimoto-Kobayashi S. Glycine betaine in beer as an antimutagenic substance against 2-chloro-4-methylthiobutanoic acid, the sanma-fish mutagen. Mutat. Res. 439:1999;267-276.
31. Yoshikawa T., Kimura S., Hatano T., Okamoto K., Hayatsu H., Arimoto-Kobayashi S. Pseudouridine, an antimutagenic substance in beer towards N-methyl-N′-nitro-N-nitrosoguanidine (MNNG). Food Chem. Toxicol. 40:2002;1165-1170.
32. Miranda C.L., Aponso G.L., Stevens J.F., Deinzer M.L., Buhler D.R. Prenylated chalcones and flavanones as inducers of quinone reductase in mouse Hepa 1c1c7 cells. Cancer Lett. 149:2000;21-29.
33. Ames B.N., McCann J., Yamasaki E. Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test. Mutat. Res. 31:1975;347-364.
34. Matsushima T., Hayashi M., Matsuoka A., Ishidate M. Jr., Miura K.F., Shimizu H., Suzuki Y., Morimoto K., Ogura H., Mure K., Koshi K., Sofuni T. Validation study of the in vitro micronucleus test in a Chinese hamster lung cell line (CHL/IU). Mutagenesis. 14:1999;569-580.
35. Xu M., Bailey A.C., Hernaez J.F., Taoka C.R., Schut H.A., Dashwood R.H. Protection by green tea, black tea, and indole-3-carbinol against 2-amino-3-methylimidazo[4,5-f]quinoline-induced DNA adducts and colonic aberrant crypts in the F344 rat. Carcinogenesis. 17:1996;1429-1434.
36. Pool-Zobel B.L., Bertram B., Knoll M., Lambertz R., Neudecker C., Schillinger U., Schmezer P., Holzapfel W.H. Antigenotoxic properties of lactic acid bacteria in vivo in the gastrointestinal tract of rats. Nutr. Cancer. 20:1993;271-281.
37. Nozawa H., Yoshida A., Tajima O., Katayama M., Sonobe H., Wakabayashi K., Kondo K. Intake of beer inhibits azoxymethane-induced colonic carcinogenesis in male Fischer 344 rats. Int. J. Cancer. 108:2004;404-411.
38. Sugiyama C., Shinoda A., Hayatsu H., Negishi T. Inhibition of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline-mediated DNA-adduct formation by chlorophyllin in Drosophila. Jpn. J. Cancer Res. 87:1996;325-328.
39. Henderson M.C., Miranda C.L., Stevens J.F., Deinzer M.L., Buhler D.R. In vitro inhibition of human P450 enzymes by prenylated flavonoids from hops, Humulus lupulus. Xenobiotica. 30:2000;235-251.
40. Kassie F., Rabot S., Uhl M., Huber W., Qin H.M., Helma C., Schulte-Hermann R., Knasmuller S. Chemoprotective effects of garden cress (Lepidium sativum) and its constituents towards 2-amino-3-methyl-imidazo[4,5-f] quinoline (IQ)-induced genotoxic effects and colonic preneoplastic lesions. Carcinogenesis. 23:2002;1155-1161.
41. Miyata M., Takano H., Takahashi K., Sasaki Y.F., Yamazoe Y. Suppression of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced DNA damage in rat colon after grapefruit juice intake. Cancer Lett. 183:2002;17-22.
42. Hagiwara A., Miyashita K., Nakanishi T., Sano M., Tamano S., Kadota T., Koda T., Nakamura M., Imaida K., Ito N., Shirai T. Pronounced inhibition by a natural anthocyanin, purple corn color, of 2-amino-1-methyl-6-phenylimidazo[4,5- b]pyridine (PhIP)-associated colorectal carcinogenesis in male F344 rats pretreated with 1,2-dimethylhydrazine. Cancer Lett. 171:2001;17-25.
43. Hagiwara A., Yoshino H., Ichihara T., Kawabe M., Tamano S., Aoki H., Koda T., Nakamura M., Imaida K., Ito N., Shirai T. Prevention by natural food anthocyanins, purple sweet potato color and red cabbage color, of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-associated colorectal carcinogenesis in rats initiated with 1,2-dimethylhydrazine. J. Toxicol. Sci. 27:2002;57-68.